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Laparoscopic Surgery: Background
The main aim of minimally invasive surgery is to reduce intra-
operative injury. This goal has occupied many surgeons, physicians, 
and scientists for over 100 years. As such, the history of laparo-
scopic surgery started in Dresden in 1901 when Kelling performed 
the first procedure of this kind. 8 years later, the internist Jacobsen 
published his first endoscopic diagnostics in the thorax and later on 
a human abdomen, and so keyhole surgery was born [1].
A quantum leap towards this goal occurred when the television 
started to be used for indirect observation. In 1972, Clarke pat-
ented, recorded, and published the first film of laparoscopic sur-
gery [2], and the first laparoscopic appendectomy was performed 
by Semm at the University of Kiel in 1981 [3]. Over the years, the 
instruments needed for laparoscopy got better, smaller, and easier 
to use. With the development of staplers, laparoscopic surgery 
evolved even further, improving its quality and diversity.
Over the past few decades, laparoscopic surgery has gone 
through various evolutionary stages, which were certainly in line 
with the general industrial progress. At first, the hand- and laparo-
scopically assisted interventions were carried out. Later on, these 
methods evolved into totally intracorporeal techniques. As a next 
step forward, port quantity was further reduced, giving rise to sin-
gle-port surgery. Recently, with the invention of mini-laparoscopy, 
a reduction in port sizes to 2 mm has been attempted. Due to these 
changes, the surgical armamentarium of many different laparo-
scopic techniques has now evolved to comprise many different mo-
dalities, such as hand-assisted laparoscopic surgery (HALS), lapa-
roscopically assisted techniques, totally intracorporeal laparoscopic 
surgery (TILS), single-incision laparoscopic surgery (SILS), flexible 
laparoscopy (FLS), and robotically assisted laparoscopic surgery 
(RALS) [4].
Robotically assisted surgery was introduced, amongst other 
techniques, to increase the precision and quality of the performed 
operations, evolving from simple camera maneuvering to very 
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Summary
Background: Reduction in operative trauma along with 
an improvement in endoscopic access has undoubtedly 
occupied surgical minds for at least the past 3 decades. It 
is not at all surprising that minimally invasive colon sur-
gery has come a long way since the first laparoscopic 
appendectomy by Semm in 1981. It is common knowl-
edge that the recent developments in video and robotic 
technologies have significantly furthered advancements 
in laparoscopic and minimally invasive surgery. This has 
led to the overall acceptance of the treatment of benign 
colorectal pathology via the endoscopic route. Malignant 
disease, however, is still primarily treated by conven-
tional approaches. Methods and Results: This review ar-
ticle is based on a literature search pertaining to ad-
vances in minimally invasive colorectal surgery for the 
treatment of malignant pathology, as well as on personal 
experience in the field over the same period of time. Our 
search was limited to level I and II clinical papers only, 
according to the evidence-based medicine guidelines. 
We attempted to present our unbiased view on the sub-
ject relying only on the evidence available. Conclusion: 
Focusing on advances in colorectal minimally invasive 
surgery, it has to be stated that there are still a number 
of unanswered questions regarding the surgical man-
agement of malignant diseases with this approach. 
These questions do not only relate to the area of bound-
aries set for the use of minimally invasive techniques in 
this field but also to the exact modality best suited to the 
treatment of every particular case whilst maintaining 
state-of-the-art oncological principles.
© 2016 S. Karger GmbH, Freiburg
Published online: June 8, 2016
W. Konrad Karcz, MD, PhD, PHM
Klinik für Allgemeine, Viszeral-, Transplantations-, Gefäß- und Thoraxchirurgie
Klinikum der Ludwig-Maximilians-Universität
Marchioninistraße 15, 81377 München, Germany
konrad @ drkarcz.de
© 2016 S. Karger GmbH, Freiburg
2297–4725/16/0323–0192$39.50/0
Minimally Invasive Surgery for the Treatment of 
CRC
Visc Med 2016;32:192–198 193
complex movements, which could not be carried out by means of 
traditional laparoscopy. The development is still a working pro-
gress, which is evident by the appearance of new devices combin-
ing flexible endoscopy and laparoscopy, i.e. ‘ANUBIS’, ‘Endo-Sam-
urai’, ‘Notes/R’, DDES, and ‘Spider’ [5–7]. This signaled the begin-
ning of natural orifice transluminal endoscopic surgery (NOTES). 
It is worthwhile pointing out that, without adding computer stabi-
lization and robotic assistance, all of these techniques would have 
achieved the end point in their development. It can also be said 
that natural orifice surgery procedures are capable of reducing 
postoperative pain and improving cosmetic results even further, as 
opposed to the other minimally invasive techniques [8].
Consequently, laparoscopic surgery is directly combined with 
the progress in video technology, whereby a better view had di-
rectly influenced the operation outcomes. The quality of view was 
initially radically improved through the introduction of high-defi-
nition television (HDTV – 1990) and then due to three-dimen-
sional views and ultra-high definition (4K (four times HD)/8K/16K 
high dynamic range). Today, it is possible to get even higher reso-
lution with the nano-pixel technology [9].
An even further enhancement of our perception could be 
achieved through certain artificial modalities. Optical-based tech-
niques, for instance, can identify tumors in the surrounding tissue 
through specific optical properties, light absorption, and scattering, 
which are primarily influenced by biochemical and morphological 
tissue composition. Breaking down optical spectroscopy, several 
further techniques can be distinguished, such as diffuse reflectance 
spectroscopy and fluorescence spectroscopy. These techniques en-
able tissue characterization by measuring the spectral response 
after the tissue is illuminated with a particular spectral band of 
light. Growing neoplasm has different properties than the tissue it 
is derived from. Its metabolism and cell composition allow differ-
entiating them from healthy tissue by using specific waves of light 
[10]. The method has been implemented in the endoscopic diag-
nostic of colorectal cancer, allowing easier identification of poten-
tial neoplasms, with sensitivity and specificity ranging from 75 to 
90% [11, 12]. A natural expansion of this technique is the current 
attempt to implement the spectroscopy method into the operating 
theater. Preliminary data showed promising results [13]. This tech-
nique will allow better identification of cancer-free margins in 
order to reduce its local recurrence. There are more methods avail-
able that help distinguishing various tissues, e.g. photodynamic di-
agnostic, photosensitizer therapy, and use of laser light. The photo-
dynamic therapy is a non-thermal approach, which can be used to 
produce localized tissue necrosis. It requires the systemic or topical 
administration of a photosensitizing agent, which is activated in 
situ by light of a specific wavelength to form reactive oxygen iso-
topes in the presence of molecular oxygen. The deployable agent 
used can represent any substance that reacts with a specific light 
length, although the most commonly used agent is 5-aminole-
vulinic acid. Currently, all trials are at animal stage but the prelimi-
nary results are promising [14]. The progress and diagnostic pos-
sibilities, also with genotyping, will lead to an early-stage diagnos-
tic and possibly to an increase of flexible endoscopic therapeutic 
options. Imaging technologies are also further developing and will 
probably be combined with videosurgery in the near future [15].
The majority of doctors do accept the superiority of minimally 
invasive techniques for the management of benign conditions. 
Colorectal surgery is no exception to this rule. The subject of lapa-
roscopic techniques in colorectal surgery raised a totally different 
question, which has been under discussion for many years. For ex-
ample, the sigmoid colectomy is the most frequently performed 
laparoscopic colorectal procedure and is already very well accepted 
by patients. Traditional open surgery is thus primarily reserved for 
very difficult cases. The limitations of laparoscopic colorectal sur-
gery are first and foremost related to its adequacy for oncological 
indications. In 2002, Lacy et al. [16] compared the treatment of 
colorectal cancer by using conventional and laparoscopic tech-
niques. Today, 5-year follow-up results are available; however, the 
question still remains open [17]. The recently published study by 
Keller et al. [18], which analyzed a 1-year prospective national in-
patient database of two patient groups who underwent colon sur-
gery by means of conventional laparotomy versus laparoscopy, 
presented a good example of the realities associated with the usage 
of laparoscopic techniques. The analysis of 6,343 patients led to the 
conclusion that the laparoscopic approach was more cost-effective 
and had better outcomes than open surgery. The authors con-
cluded that minimally invasive surgery is a standard that should be 
offered to all patients [18]. It has been shown that laparoscopy sig-
nificantly improves postoperative recovery and patient satisfaction, 
shortens length of stay, and reduces complication and readmission 
rates, with similar results compared to open surgery for benign and 
malignant colorectal neoplasms [17, 19–23]. It has to be said that 
the data presented by Keller et al. [18] showed that about 50% of all 
patients in the USA were operated using the laparoscopic ap-
proach, whereas in England, this figure was only 20% in 2010. In 
Germany, there is a role for laparoscopic surgery in managing be-
nign and malignant diseases of the colon and rectum [18, 24]. 29 
years after the foundation of laparoscopic surgery, we still have 
questions regarding the boundaries for oncological application of 
these techniques. Some interesting results were published by the 
well-designed ACOSOG-Z6051 trial (35 surgical institutions) 
where the non-inferiority thesis of laparoscopy in comparison to 
open surgery was supported according to pathological outcomes. 
Nonetheless, it was concluded that in order to achieve better onco-
logical clinical outcomes, more advanced neoplasms and cancer 
stages should be treated by means of open surgery [25]. Established 
laparoscopic oncological colon surgery has to be compared with its 
further developments such as SILS and RALS to recognize its ad-
vantages and restrictions.
Advanced Clinically Approved Laparoscopic  
Techniques
Single-Incision Laparoscopic Surgery
The reduction of the number of access ports as opposed to con-
ventional laparoscopy (CL) led to the development of single-port 
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laparoscopic surgery. It was pioneered by Pelosi who first reported 
on SILS hysterectomy in 1992 [26]. The first colorectal operations 
which were carried out using this technique were the treatment of 
appendicitis [27] and sigmoid diverticulitis [4]. In today’s practice, 
those techniques continue to expand but still have limitations. By 
direct comparison to multi-port laparoscopy, the following disad-
vantages have to be pointed out: lack of triangulation; different, 
sometimes uncomfortable position for the surgeon; no ergonomic 
position for the assistant; restricted number of working instru-
ments; restricted external working space; need for additional spe-
cial equipment, which in turn extends operating time and prolongs 
the learning curve [28] (fig.  1). New operative instruments were 
necessary to improve this technique, e.g. long scope with 5-mm di-
ameter, curved laparoscopic instruments, articulated instruments 
etc. The variety of equipment available on the market for single-
port technique rapidly increased in 2012 [29, 30]. Today, both 
techniques, i.e. CL and SILS, are also successfully used in oncologi-
cal colon surgery. It has to be noted that since its development, 
SILS showed only moderate growing dynamics. The complexity of 
oncological techniques resulted in minimally invasive operations 
being special and very difficult. There are only few higher evi-
dence-based publications which directly compare the SILS and CL 
procedures, and some of them were pre-planned studies. In the 
SILVERMAN1 trial, Winter et al. [31] proposed a prospective, 
well-structured trial to observe the differences in SILS and CL pro-
cedures for hemicolectomy for colonic cancer. Overall, it seemed 
that the SILS technique could be used to perform right hemicolec-
tomy with quite good comparable results from 300 patients ex-
pected by the end of 2016 [31]. In 2010, Ramos-Valadez et al. [32] 
had already published a study with positive conclusions for SILS 
for the right colon surgery. Unfortunately, his observation cohort 
had only 11 patients [32]. In 2011, Kim et al. [33] initiated a trial to 
prospectively compare CL with single-port colon resections. The 
primary outcome of this trial showed no difference between the 
groups, but the technical difficulties with SILS were pointed out 
[33]. Furthermore, an interesting prospective randomized trial was 
recently published by Wang et al. [34]; here, early morbidity was 
used as an end point. In this paper, technical difficulties such as 
limitations relating to the instrument movement, loss of triangula-
tion, difficulties with rectal transection, and intracorporeal double-
stapling of anastomoses were also pointed out. Additionally, the 
need to use an additional 12-mm trocar in the SILS technique was 
regarded as problematic [34]. In contrast, Marks et al. [35], in his 
retrospective study, presented slightly better results for SILS proce-
dures in respect to operative time, incision, and blood loss. Lee et 
al. [36] published different results for the left hemicolectomy oper-
ative time, where SILS operations lasted longer in comparison with 
HALS and classical multi-port technique. The use of independent 
parameters like inflammatory response as well as immune re-
sponse, as proposed by Wang et al. [34], could enable a completely 
new, independent angle for comparing the laparoscopic operation 
techniques. Some studies showed that the oncological safety of 
SILS has not been completely proven. Local recurrence rate or dis-
tant metastasis may still pose an issue. There are studies showing 
oncological safety with SILS; however, this has to be better evalu-
ated through higher evidence-based studies with longer observa-
tion time, i.e. disease-free survival or 5-year survival [34, 37]. Nev-
ertheless, the early results are promising for SILS. In contrast, 
Chew et al. [38] reported no difference between SILS and CL for 
right hemicolectomy procedures according to lymph node count in 
the resected specimen.
Rectal cancer is even more challenging, particularly technically, 
when compared to colon SILS procedures, especially when the dis-
tance between the umbilicus and the sacrum or spleen is larger or 
when the patients’ body mass index (BMI) is higher. These consid-
erations have undoubtedly influenced the pre-selection processes 
[39]. Amongst other aspects, single-incision TME techniques need 
to counter the tension of the new instruments, which poses further 
limitations [40]. It is worth mentioning that single-port techniques 
were mostly used for segmental colon resections and achieved the 
lowest rates of complications compared to CL and RALS [6, 36, 
41]. However, meta-analyses have pointed out that the patients’ 
BMI was very low in the SILS group when compared to the normal 
population [42]. Cianchi et al. [30] explained that the results after 
SILS surgery are strongly correlated with the level of surgical skills 
when approaching the technique (which needed to be high), pre-
selection of patients with smaller tumors, lower BMI, and right-
sided pathology. Nevertheless, SILS procedures are still not widely 
adopted in colorectal surgery due to the fact that they are associ-
ated with technical challenges, i.e. not an ergonomic position for 
the operator, higher procedural skills of the operator, and most 
certainly higher costs [43, 44].
Robotically Assisted Laparoscopic Surgery
It is not surprising that the history of medical robots overlaps 
with laparoscopy, although robots did appear a few years prior to 
laparoscopy, namely with the ‘Puma 560’ used for neurosurgical 
biopsy in 1985. Several years later, this led to the development of 
Fig. 1. Applied Medical gel port for single-incision laparoscopic surgery 
(courtesy of Applied Medical Resources®).
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the ‘Probot’ for transurethral resection of the prostate. Simultane-
ously, the ‘Robodoc’ was created by IBM’s Thomas J. Watson Re-
search Center for total hip arthroplasty. There were also some 
NASA projects in the 1980s which focused on developing telesur-
gery and further accelerated the development of the robots used in 
surgery. The situation was also strongly influenced by the US Army 
projects with Mobile Advanced Surgical Hospitals (MASH) where 
wounded soldiers could be loaded into a vehicle with robotic 
equipment and be operated by a surgeon of MASH.
First commercial voice-controlled endoscopic cameras were de-
veloped by Computer Motion Inc. and were called AESOP (Auto-
mated Endoscopic System for Optimal Positioning); later, they were 
followed by ZEUS (fig. 2). AESOP development led to the ‘da Vinci’ 
system, which is the most popular RALS platform in the world 
nowadays. Progress in using robotic surgery was influenced even 
more by the extension and improvement of laparoscopic operative 
techniques. Germany also contributed to the history of employing 
robotic surgery after F.-W. Mohr had successfully carried out the 
first robotically assisted heart bypass in Leipzig in 1998. In 2008, the 
German Aerospace Center (DLR) presented the first robotic system 
for minimally invasive surgery [45–59] (fig. 3). In 2011, there were 
already 1,400 operating rooms equipped with ‘da Vinci’ systems in 
the USA. The higher costs slowed down the development of this 
technique in the Eurozone due to the limitations of the social insur-
ance systems, and Germany was not an exception to this rule, thus 
resulting in only 52 working RALS systems in 2011 [50]. It is need-
less to say that colorectal surgery could also be performed via lapa-
roscopy with robotic assistance [6]. However, we will analyze the 
scientific literature to form an independent view on this topic. It 
could be said that because of the disproportional operational costs, 
the fast development of RALS in the USA had a background of a 
combination of both excellent marketing performance and patients’ 
needs for modern technology. The meta-analysis by Tewari et al. 
[51] on 286,876 prostatectomies showed that oncological margins 
were comparable yet suggested that the adverse events decreased 
when using robotically assisted procedures. Furthermore, the lower 
readmission, reoperation, and total perioperative complication 
rates supported a lower morbidity with RALS. Although these stud-
ies were very good, it has to be noticed that duration of a robotic 
procedure, preparation time for surgery, learning curve, and costs 
were not analyzed [51]. Currently, we do not have large numbers of 
RALS techniques used in colorectal surgery. A very interesting 
comparison was published by Keller et al. [52], focusing on CL, 
SILS, and RALS procedures in colorectal surgery. The study had 
several restrictions, e.g. analysis of non-homogeneous groups, time 
of publication, small patient cohorts etc. However, the technical 
trends of the operations were suitable for evaluation. Firstly, in 
comparison to first publications about 20 years ago, CL has im-
proved the outcomes, and secondly, because of technical restric-
tions, RALS was mainly used for rectal cancer [53]. The advantages 
of RALS were: comfortable position for the surgeons, reduction of 
physiological tremors, physiological position of hands, structure 
view enlargement, almost unrestricted motion of instruments, su-
perior dexterity, permanent 3D view, etc. [54, 55]. Where limita-
tions of movement (e.g. narrow spaces) exist, the advantages of ro-
botically assisted surgery are obvious. Comparing traditional lapa-
roscopic instruments with the possibilities of robotic instruments, 
i.e. rotation (up to 540°), flexion (180°) clearly emphasizes the limi-
tations of CL [56]. Having said that, the robotic systems also had 
limitations which were associated with its usage in a wider operative 
field, such as in cases of rectal surgery, involving its mobilization 
with the need to mobilize the left colonic flexure during the same 
procedure [54]. Such changes in operative quadrants when using 
RALS are associated with re-docking of the system, trocar reposi-
tioning, or additional trocar placement. This consequently led to 
the development of hybrid techniques, where a part of the opera-
tion is carried out by means of standard laparoscopy, with conse-
quent time prolongation or use of an additional surgeon for the ro-
botically assisted part of the procedure [55, 57]. In contrast, many 
authors reported no difference in outcome between hybrid and soli-
tary RALS [58–60]. Keller et al. [61] analyzed the operative time of 
robotically assisted procedures, which was longer in the same series. 
Fig. 2. Clinical approach: robotically supported 3D laparoscopic surgery at 
the University of Freiburg, Germany.
Fig. 3. DLR MiroSurge System for robotically assisted laparoscopic surgery 
(courtesy of Mr. Holger Urbanek, Institut für Robotik und Mechatronik, 
Deutsches Zentrum für Luft- und Raumfahrt).
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Moreover, the complication and readmission rates were higher than 
in multi- or single-port surgery. It has to be critically pointed out 
that the preoperative robotic system preparation time was always 
significantly longer, thereby prolonging the use of the operating 
theater [62]. The same observation was reported by Patel et al. [63] 
upon comparing RALS, CL, and HALS, with similar short clinical 
results in all groups. The mortality rate was analyzed by Keller et al. 
[52]; no differences were found and the study concluded that CL, 
RALS, and SILS enable high-quality colorectal surgery [52]. To 
evaluate the conversion rate, which is an excellent laparoscopic 
quality characteristic, more than 60 different studies on RALS and 
CL were analyzed, showing average conversion rates to open sur-
gery of 2.4 and 0.7%, respectively [62]. In oncological colon surgery, 
however, the prognosis and outcome for the use of robotically as-
sisted procedures are yet to be evidence base evaluated. The very 
frequent usage of RALS in the pelvis could be the reason for the re-
sults presented by Baik et al. [64], where better prognosis and onco-
logic outcomes were concluded. There are also studies where the 
amount of blood loss after colon surgery by robotically assisted pro-
cedures seemed to decline [65, 66]. It is too early to talk about the 
disease-free survival rates but small published series showed similar 
outcomes to CL [67, 68]. It is certain that total mesorectal excision 
(TME) resection could create an interesting further chapter of ro-
botically assisted approaches due to a small operative field and 
closely placed anatomical structures. The first publication on the 
use of robots in oncological cases was written by Pigazzi et al. [69] 
in 2006. The meta-analysis by Araujo et al. [56] presented 32 studies 
with 1,776 patients who underwent robotically assisted procedures 
on the rectum. Generally, the postoperative complication rate was 
comparable in most of the evaluated studies. Only in one well de-
signed cohort by Baik et al. [70], the reduction of complications was 
significantly smaller for RALS [56]. The oncological assessments 
demonstrated similar results in achieving adequate circumferential 
resection margin, lymph node count, distal resection margin, etc. 
[58]. The ROLLAR (RObotic Versus LAparoscopic Resection for 
Rectal Cancer) trial presented at the international congress of the 
European Association for  Endoscopic Surgery (EAES) in 2015 
showed no better outcomes for robotic surgery [71]. However, it is 
already proven that robotic surgery is safe and comparable with 
conventional or laparoscopic surgery. Nonetheless, if costs for 
RALS surgery were optimized and the technology was better taught 
and widely accepted, then robotic surgery would be able to decrease 
the percentage of laparoscopic operations and would have a fixed 
place in oncological colon  surgery, especially in difficult cases with 
narrow, small operative fields and, naturally, in cases involving so-
phisticated surgical reconstructions.
Endoscopic Local Tumor Resections
By definition, the term NOTES in colorectal surgery involves 
endoscopic resections of local colorectal tumors. The technique 
has been used for several years and resulted in many different 
modifications. The first endoscopic method for local tumor man-
agement was transanal endoscopic microsurgery (TEM), which 
was developed by Buess in 1983 [72]. Since then it has gradually 
gained acceptance and replaced the standard transanal excision 
due to its benefits of quick learning curve and better augmentation 
of the  excised area. In a meta-analysis, Clancy et al. [73] proved 
better oncological results when using TEM instead of standard ex-
cision. TEM is consequently an established approach, which offers 
a stable operating platform with magnified stereoscopic view, thus 
allowing precise full-thickness excision of the rectal wall as far as 
15–20 cm from the anal verge. TEM for rectal cancer could remove 
the primary tumor but, unlike TME, is not able to remove the mes-
orectal lymph nodes. Thus, it is important to determine the pres-
ence of metastases in lymph nodes prior to surgery. The novel 
method that is currently being developed and which still needs to 
be proven as safe and efficient is transanal minimally invasive sur-
gery (TAMIS) [74]. Its preliminary results are promising but re-
quire more research. With the development of new and more so-
phisticated equipment, endoscopic resections have been combined 
with other surgical techniques to create more applicable and safer 
methods. Transanal TME (taTME) is the combination of the three 
established rectal surgery techniques, i.e. TME [75], transanal 
transabdominal resection/intersphincteric resection [76], and 
TEM, inspired by the recent concept of NOTES and the TAMIS 
procedure [77, 78].
A taTME has the potential benefit of better visual control of 
hard-to-access anatomical areas which would be impossible to 
reach by means of standard laparoscopic approaches, especially in 
male patients with a high BMI and low rectal cancer, thus resulting 
in open surgery. Better magnification may lead to even easier nerve 
preservation and better identification of the resection plane [79]. A 
taTME is a new approach of performing minimally invasive rectal 
resection; it attracts a lot of attention in the literature but still re-
quires a lot of research to determine its full usefulness and safety 
for future patients.
Conclusion
The topic of trauma reduction without much change to the or-
gan-specific procedures and improvement of surgical access still oc-
cupies our minds. Hence, experienced minimally invasive surgeons 
currently use very sophisticated equipment to further improve the 
already good quality of surgical colon procedures and take them to 
yet another level. In the future, minimally invasive surgery will fur-
ther reduce the organ-dependent approach and will represent only 
a part of interdisciplinary therapy. The development of tailored in-
dividualized oncological approaches and diagnostic techniques will 
most likely reduce the range of available surgical interventions. Fur-
ther development of endoscopic surgical equipment will improve 
the safety and quality of minimally invasive videosurgery.
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